May 12, 2025 - 22:08

In a recent corporate update, Black Diamond Therapeutics revealed significant advancements in its clinical trials and financial standing for the first quarter of 2025. The company is on track to present clinical data from its Phase 2 trial of BDTX-1535, targeting first-line patients with non-classical EGFR mutations in non-small cell lung cancer (NSCLC), with results expected in the fourth quarter of 2025.
Additionally, the company has initiated an expansion of its investigator-sponsored Phase 0/1 trial, focusing on newly diagnosed glioblastoma patients with EGFR alterations. This expansion commenced in the first quarter of 2025, reflecting the company’s commitment to exploring innovative treatment options for challenging cancers.
Financially, Black Diamond Therapeutics reported cash, cash equivalents, and investments totaling $152.4 million as of March 31, 2025. This financial position is anticipated to adequately support the company’s operations through to the fourth quarter of 2027, ensuring continued progress in its clinical and research endeavors.
May 22, 2026 - 02:54
Q1 Earnings Outperformers: LPL Financial (NASDAQ:LPLA) And The Rest Of The Investment Banking & Brokerage StocksQuarterly earnings season offers a clear snapshot of how companies are navigating the current market, especially when stacked against direct competitors. In the investment banking and brokerage...
May 21, 2026 - 18:31
Stock market today: Dow clinches record high, S&P 500 and Nasdaq rise as stocks rebound on US-Iran peace hopesWall Street closed higher on Tuesday, with the Dow Jones Industrial Average securing a new record high, while the S&P 500 and Nasdaq also posted gains. The broad market rally was fueled by renewed...
May 21, 2026 - 08:48
Greek finance minister hails troika reforms as ‘absolutely necessary’Greece`s finance minister, Kyriakos Pierrakakis, has described the strict reforms imposed by international creditors more than a decade ago as `absolutely necessary` for the country`s current...
May 20, 2026 - 23:59
NVIDIA Announces Financial Results for First Quarter Fiscal 2027NVIDIA has announced its financial results for the first quarter of fiscal 2027, posting record revenue of $81.6 billion. That figure marks an 85 percent jump compared to the same period a year ago...